ANTIMICROBIAL RESISTANCE RESEARCH CAPITAL FUNDING
| Dates: | 26 October 2018 |
|---|
| Times: | 16:00 - 16:00 |
|---|
| What is it: | Academic calendar |
|---|
| Organiser: | Faculty of Biology, Medicine and Health |
|---|
| Who is it for: | University staff |
|---|
|
|
The NIHR has launched an open competition to allocate up to £32 million of a Department of Health and Social Care (DHSC) funding to provide capital investment in buildings (including refurbishment) and/or equipment to strengthen UK-based capacity and capability in AMR research. Applications are expected to be ~ £1-6 million over 2 years, with the capital component the major cost. Seed funding costs can be applied for to carry out small research studies (e.g. pilot or scoping projects) in the following areas:
• Infection Prevention and Control
• Novel interventions to prevent and treat healthcare-associated infections and infectious disease (except HIV and tuberculosis)
• Effective use of current antimicrobials
• Diagnostics (except early stage development of new diagnostic approaches)
The NIHR deadline for applications is 6th December 2018 and further information on the call can be found here and attached.
All NHS Trusts, Higher Education Institutions and not-for-profit UK research organisations within the UK are eligible to apply, but only a single application can be submitted by each organisation. The Evolution, Systems and Genomics Domain is collecting expressions of interest for the call, in conjunction with Manchester BRC. If you are interested in being involved in an application to this funding initiative please let me know by email before 16:00 on Friday 26th October, providing a brief summary of the capital and research area(s) you are proposing.
Sarah.george-2@manchester.ac.uk
Strategic Funding Manager for the Evolution, Systems and Genomics Domain
Tel. 0161 306 5592
sarah.george-2@manchester.ac.uk
Travel and Contact Information
